ArticleCancer medicine2021

Early hypertension and neutropenia are predictors of treatment efficacy in metastatic colorectal cancer patients administered FOLFIRI and vascular endothelial growth factor inhibitors as second-line chemotherapy.

Hiroki Osumi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.